Frontiers in Endocrinology

Immune protein shapes bone mass differently in female and male mice

Tracking mice lacking the immune protein interleukin-4 from 2 to 20 months revealed lower peak spongy bone mass in females and age-related bone loss in males.

Paper by Sadaf Dabeer, Ji Ae Lee, Daiana Weiss et al.

Spongy bone with dense and broken struts surrounds a dark bone-breaking cell, beside small laboratory mice and denser and sparser bone sections.

Our read

Mechanisms
Studied:
Accepted, not yet published: experiments in male and female IL-4 knockout mice
What changed:
Females lacking IL-4 had lower peak spongy bone mass; males reached normal peaks, then lost bone with age
The catch:
Lifelong genetic changes do not measure effects of targeting the pathway later in life
In the record:
One of 83 papers on IL4 on record: 1 with results in people, 5 in animals.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Male and female mice lacking the gene for interleukin-4, an immune signaling protein, were studied from 2 to 20 months of age in an animal experiment. The researchers examined trabecular bone, the spongy bone inside the skeleton.

Females failed to reach normal peak spongy bone mass but developed no additional deficit afterward. Males reached normal peak bone mass, then developed severe, progressive age-related loss of spongy bone. This loss was associated with increased bone breakdown and reduced bone formation. In a separate genetic experiment, the researchers deleted the receptor that receives interleukin-4 signals in the family of cells that includes bone-breaking cells. These mice also had reduced spongy bone mass in both sexes at 10 months.

Why it matters

Age-related bone loss makes understanding the immune system’s role in skeletal maintenance important. The authors suggest that disrupted interleukin-4 signaling may contribute to bone loss associated with immune dysfunction and identify it as a potential therapeutic target.

Caveats

Lifelong genetic changes in mice do not show whether targeting this signaling pathway later in life would preserve bone in people.

Where the evidence stands

IL4

Mice and humans: a single group. Cells and worms or flies: nothing yet.
  • 5 independent labs in 6 countries
  • Funders: Agence Nationale de la Recherche and others
  • 2 of 7 findings with company ties

IL4RA

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 3 independent labs in 2 countries

Comments

Be the first to comment.